Quince Therapeutics | 4:持股變動聲明-董事 Patni Rajiv
Quince Therapeutics | 3:首次持股聲明-董事 Patni Rajiv
Quince Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(7.5%),Tang Capital Management, LLC(7.5%)等
Quince Therapeutics | SC 13G:超過5%持股股東披露文件-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%)等
Quince Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BML Investment Partners, L.P.(0.0%),Braden M Leonard(0.0%)
Quince Therapeutics | 4:持股變動聲明-高管 Ryan Charles S.
Quince Therapeutics | 4:持股變動聲明-高管 Hannah Brendan
Quince Therapeutics | 4:持股變動聲明-高管 Thye Dirk
Quince Therapeutics | 4:持股變動聲明-高管 Thye Dirk
Quince Therapeutics | 4:持股變動聲明-董事 Lamond David
Quince Therapeutics | SC 13G:超過5%持股股東披露文件-Genextra S.p.A.(5.89%),Francesco Micheli(5.89%)等
Quince Therapeutics | 4:持股變動聲明-董事 Lamond David
Quince Therapeutics | 4:持股變動聲明-董事 Lamond David
Quince Therapeutics | 4:持股變動聲明-高管 Hannah Brendan
Quince Therapeutics | 4:持股變動聲明-董事 Benatti Luca
Quince Therapeutics | 3:首次持股聲明-董事 Benatti Luca
Quince Therapeutics | 4:持股變動聲明-高管 Janhofer Guenter
Quince Therapeutics | 3:首次持股聲明-高管 Janhofer Guenter
Quince Therapeutics | 4:持股變動聲明-總裁 Ryan Charles S.
Quince Therapeutics | 3:首次持股聲明-總裁 Ryan Charles S.
暫無數據